In models of gestational diabetes mellitus, increased immune markers, including TLR4, TLR5, IL-22, and IL-23, have been detected in the placenta, suggesting a role for TLR4 and TLR5 in the inflammatory processes associated with maternal metabolic disturbances [88]. The gene discussed is TLR5; the disease is gestational diabetes.